BIOA
BioAge Labs, Inc.NASDAQHealthcare$17.50-1.30%ClosedMarket Cap: $629.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.32
P/S
70.12
EV/EBITDA
-5.43
DCF Value
$8.57
FCF Yield
-13.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.2%
Operating Margin
-1031.5%
Net Margin
-896.1%
ROE
-27.9%
ROA
-27.3%
ROIC
-33.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $3.1M | 97.8% | $-28.4M | $-25.9M | $-0.72 | — |
| FY 2025 | $9.0M | 100.0% | $-92.8M | $-80.6M | $-2.24 | — |
| Q3 2025 | $2.1M | 100.0% | $-23.1M | $-20.2M | $-0.56 | — |
| Q2 2025 | $2.4M | 100.0% | $-24.8M | $-21.6M | $-0.60 | — |
| Q1 2025 | $1.5M | 100.0% | $-16.4M | $-12.9M | $-0.36 | — |
| Q4 2024 | $0.00 | NaN% | $-25.4M | $-21.1M | $-1.97 | — |
| FY 2024 | $0.00 | NaN% | $-78.2M | $-71.1M | $-6.63 | — |
| Q3 2024 | $0.00 | NaN% | $-24.8M | $-23.4M | $-6.70 | — |
| Q2 2024 | $0.00 | NaN% | $-15.3M | $-13.6M | $-1.80 | — |
| Q1 2024 | $0.00 | NaN% | $-12.8M | $-13.0M | $-1.74 | — |
| Q4 2023 | $0.00 | NaN% | $-13.6M | $-21.0M | $-2.81 | — |
| FY 2023 | $0.00 | NaN% | $-48.4M | $-63.9M | $-8.55 | — |